A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
BACKGROUND: Dengue is the most common arboviral infection of humans. There are currently no specific treatments for dengue. Balapiravir is a prodrug of a nucleoside analogue (called R1479) and an inhibitor of hepatitis C virus replication in vivo. METHODS: We conducted in vitro experiments to determ...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Journal Article |
| Langue: | anglais |
| Publié: |
2018
|
| Accès en ligne: | https://demo7.dspace.org/handle/123456789/191 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires: A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
- Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
- Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam
- Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
- Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- Value perception in ultimatum game: a blinded randomized trial